About
Technology
Issues
FAQ
Links
Official Page
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.